Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-16

FDA Approved: TOLVAPTAN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' tolvaptan via an original (ANDA) application, indicating a generic tolvaptan product is approved.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)